65814 Federal Register / Vol. 62, No. 241 / Tuesday, December 16, 1997 / Notices

RR. The authority vested in the

Secretary or that may become vested in

the Secretary, and not otherwise

delegated, limited, or reserved, to

conduct studies and demonstration

projects, as directed by Congress, that

relate to the programs established by

Title XI of the Social Security Act (Act),

insofar as they relate to the mission of

the Health Care Financing

Administration (HCFA), and Titles

XVIII, XIX, and XXI. This delegation

encompasses the authority to approve

related program activities required by

the studies and demonstration projects

if such authority is or becomes vested in

the Secretary and is not otherwise

delegated, limited, or reserved. These

activities include, but are not limited to,

direct performance, entering into

contracts or cooperative agreements,

making grants, approving payments for

contracts, cooperative agreements, and

grants and approving authorized

waivers of compliance with certain

requirements of titles XI, XVIII, and XIX

and XXI of the Act when such actions

are for the purpose of conducting

studies and demonstration projects.

This delegation shall be exercised

under the Department’s existing

delegation of authority and policy on

regulations. In addition, I hereby ratify

and affirm any actions taken by the

Administrator or other HCFA officials

which, in effect, involved the exercise of

this authority prior to the effective date

of this delegation. This delegation is

effective immediately.

Dated: December 2, 1997.

Donna E. Shalala,

Secretary.

[FR Doc. 97–32747 Filed 12–15–97; 8:45 am]

BILLING CODE 4120–03–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: Cancer Education Program,

Telephone Conference Call.

Date: December 18, 1997.

Time: 3:30 p.m. to Adjournment.

Place: National Cancer Institute, Executive

Plaza North, Room 611A, 6130 Executive

Boulevard, Bethesda, MD 20892.

Contact Person: Mary Bell, Ph.D., Scientific

Review Administrator, National Cancer

Institute, NIH, Executive Plaza North, Room

611A, 6130 Executive Boulevard, Bethesda,

MD 20892, Telephone: 301/496–7978.

Purpose/Agenda: To review, discuss and

evaluate grant applications.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Grant applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

proposals, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower,

93.399, Cancer Control.)

Dated: December 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32745 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN RESOURCES

National Institutes of Health

Electric and Magnetic Fields Research

and Public Information; Dissemination

(EMFRAPID) Program; Environmental

Toxicology Program, Office of Special

Programs; National Institute of

Environmental Health Sciences,

National Institutes of Health

NOTICE: Second EMF Science Review

Symposium—EMFRAPID Program.

Background

The National Institute of

Environmental Health Sciences (NIEHS)

and the Department of Energy (DOE) are

coordinating the implementation of the

Electric and Magnetic Fields (EMF)

Research and Public Information

Dissemination (RAPID) Program.

EMFRAPID was established by the 1992

Energy Policy Act (Section 2118 for

Public Law 102–486) which was signed

in October 1992. This five-year effort is

designed to determine the potential

effect from exposure to 60 Hz electric

and magnetic fields on biological

systems, especially those produced by

the generation, transmission and use of

electric energy. DOE is responsible for

characterizing field exposures and for

mitigating exposures which may be

hazardous. The NIEHS is responsible for

the development and implementation of

a research program on the possible

human health effects of electric and

magnetic fields (EMF). The RAPID

Program requires the NIEHS to report on

the extent to which exposure to electric

and magnetic fields adversely affects

human health.

The NIEHS has three groups that

assist in managing and directing the

science portion of RAPID and who will

provide guidance on reporting on the

health effects of electric and magnetic

fields. The first, known as the

Interagency Agency Committee on

Electric and Magnetic Fields (IAC) is

composed of representatives from 10

federal agencies with responsibilities

related to electric and magnetic fields

(DOE, NIEHS, the Environmental

Protection Agency (EPA), the

Department of Defense (DOD), the

Occupational Safety and Health

Administration (OSHA), the National

Institute of Standards and Technology

(NIST), the Department of

Transportation (DOT), the Rural

Electrification Administration (REA),

the Department of the Interior (DOI),

and the Federal Energy Regulatory

Commission (FERC)). The IAC,

established by the President of the

United States, must also prepare a final

report for Congress.

The second is the National Electric

and Magnetic Field Advisory Committee

(NEMFAC). NEMFAC consists of

representatives from public interest

groups, organized labor, state

governments, academia, and industry.

This groups advises DOE and NIEHS on

the design and implementation of the

program. NEMFAC also provides

recommendations to the IAC.

Finally, the NIEHSA has an internal

EMF Steering Committee (SC) consisting

of senior scientists with broad

programmatic responsibilities and a

broad scientific perspective. The SC

manages all aspects of the EMFRAPID

Research Program at the NIEHS.

NIEHS Report on Human Health Effects

of EMF

The report development process

combines a critical evaluation of the

scientific literature with an assessment

of the strength of the evidence for

human health effects resulting from

EMF exposures. To accomplish the

initial part of this process, the NIEHS is

convening a series of open, public

symposia on science related to EMF

exposures and their biological effects for

these study areas: theoretical/in vitro

research findings, epidemiological

results, and in vivo/clinical laboratory

findings. The symposia (March 1997,

January 1998, and April 1998) provide
Federal Register / Vol. 62, No. 241 / Tuesday, December 16, 1997 / Notices 65815

a forum for the discussion and

evaluation of the research findings in

the selected area. At each symposia the

participants consider the quality and

reproducibility of the research findings

for evaluating the degree to which

scientific evidence can support a causal

linkage between EMF and biological/

health effects. Written reports

summarizing the deliberations of

breakout group discussion sessions are

publicly available for the first

symposium (send name and address to

f:919–541–0144 or from EMFRAPID

Progrm/LCBRA, NIEHS, PO Box 12233,

MD EC–16, Research Triangle Park, NC

27709). The participants for each

symposium include scientists studying

EMF effects in the science area being

reviewed, experts on measuring and

producing EMF exposures, risk

assessment experts, and recognized

scientists in the area being evaluated

who may have little EMF experience but

can contribute to a broader

understanding of the research findings.

Following the symposia a working

group meeting is planned for June 1998.

The working group will use information

from the symposia’s discussions as well

as perform on overall critical evaluation

of the literature and produce a report.

This document will draw conclusions

on the strength and robustness of the

data and its implications for human

health effects and disease etiology.

Per the request from Congress, the

NIEHS will use the final report of the

working group, information obtained

from the science review symposia and

other relevant information to prepare a

report to Congress on the potential for

human health effects from exposure to

EMF that result from the production and

distribution of electricity. This report

will be made publicly available at the

time it is sent to Congress. Detailed

information about the EMFRAPID

Program is available at the time it is sent

to Congress. Detailed information about

the EMFRAPID Program is available on

the world wide web at

www.niehs.nih.gov/emfrapid/

home.htm.

Science Review Symposium on

Epidemiology: Open to the Public

In its series of science review

symposia, the second EMF Science

Review Symposium is scheduled for

January 12–14, 1998 at the Camberley

Gunter Hotel, San Antonio, Texas. This

meeting includes plenary overview talks

on exposure assessment, methodological

issues and problems in epidemiological

studies as well as substantive talks on

disease endpoints. Breakout group

sessions are planned for in-depth

discussions of the research findings

from epidemiological studies as well as

methodological and exposure

assessment issues. This meeting is open

to the public and the registration fee is

$85; for registration information contact

t:919–541–7534 or f:919–541–0144.

Science Review Symposium on Clinical

and In vivo Research Studies

Planning is underway for the third

EMF Science Review Symposium, April

6–9, 1998 at the Hyatt Regency at Civic

Plaza, Phoenix, Arizona. To receive

additional information about this

meeting, send your name and address to

f:919–541–0144 or EMFRAPID Program/

LCBRA, NIEHS, PO Box 12233, MD EC–

16, Research Triange Park, NC 27709.

Dated: December 2, 1997.

Samuel H. Wilson,

Deputy Director, National Institute of

Environmental Health Sciences.

[FR Doc. 97–32742 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

AIDS Research Advisory Committee,

NIAID

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the AIDS Research Advisory Committee,

National Institute of Allergy and

Infectious Diseases, on January 28, 1998

in Conference Room 1A1 in the Solar

Building located at 6003 Executive

Blvd, Rockville, Maryland.

The entire meeting will be open to the

public from 8:30 a.m. until

adjournment. The AIDS Research

Advisory Committee (ARAC) advises

and makes recommendations to the

Director, National Institute of Allergy

and Infectious Diseases, on all aspects of

research on HIV and AIDS related to the

mission of the Division of AIDS

(DAIDS).

The Committee will provide advice

on scientific priorities, policy, and

program balance at the Division level.

The Committee will review the progress

and productivity of ongoing efforts, and

identify critical gaps/obstacles to

progress. Attendance by the public will

be limited to space available.

Ms. Rona L. Siskind, Executive

Secretary , AIDS Research Advisory

Committee, DAIDS, NIAID, NIH, Solar

Building, Room 2A21, telephone 301–

435–3732, will provide a summary of

the meeting and a roster of committee

members upon request. Individuals who

plan to attend and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Siskind in advance of the meeting.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health).

Dated: December 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32743 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Amended Unsolicited R01

(Telephone Conference Call).

Date: January 6, 1998.

Time: 1:00 p.m. to Adjournment.

Place: Teleconference, 6003 Executive

Blvd., Solar Building, Room 4C01, Bethesda,

MD 20892, (301) 496–2500.

Contact Person: Dr. Dianne E. Tingley,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C07,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

The meeting will be closed in accordance

with the provision set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Application and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: December 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32744 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M